Keltech Energies (506528)
CyclicalScore breakdown: P/E: 3/3 · ROCE: 2/2 · Growth: 1/2 · Dividend: 0/1
Key Financials
| Current Price | ₹3,528 |
| Market Cap | ₹355.35 Cr |
| P/E Ratio | 11.86 |
| ROCE | 25.85% |
| ROE | 24.3% |
| Dividend Yield | 0.05% |
| Profit Growth | 1.04% |
| Debt/Equity | — |
| Sales Growth | 9.15% |
| 52-Week Range | ₹2,900 — ₹5,252 |
| Sector | Chemicals & Petrochemicals |
| Book Value | ₹1,127.7 |
Strengths
- ROE of 24.30% and ROCE of 25.85% indicate strong capital efficiency and a possible franchise advantage.
- Piotroski F-Score of 7/9 points to healthy financials and operational discipline.
- P/E of 11.86 is reasonable for an industrial business with high returns.
- Sales growth of 9.15% shows demand is still expanding despite weak profit growth.
Concerns
- Profit growth of only 1.04% while sales grew 9.15% signals margin compression.
- Latest quarterly net profit of ₹6 Cr on sales of ₹128 Cr implies a thin net margin of under 5%.
- P/B of 3.13 means investors pay a steep premium to book value.
- Dividend yield of 0.05% provides negligible income support; PEG of 1.67 offers little growth-adjusted cushion.
AI Analysis
At ₹3,528, Keltech Energies is a small-cap explosives maker with a market cap of ₹355 crore. The first thing that catches my eye is capital efficiency: ROE of 24.30% and ROCE of 25.85% are excellent for any Indian business. A Piotroski F-Score of 7/9 also suggests a reasonably sound financial position. However, I cannot call this a classic Graham bargain. The P/E of 11.86 is not demanding, but P/B of 3.13 means the market is asking me to pay more than three times book for a business whose latest annual profit growth is only 1.04%. Sales grew a healthier 9.15%, but net profit growth lagged badly—latest quarter shows ₹128 crore sales translating to just ₹6 crore net profit. That suggests pricing power is weak and costs are compressing margins. Explosives is a niche sector tied to mining and infrastructure, so there may be a narrow moat, but demand is inherently cyclical. The share price is down from ₹5,252 to ₹3,528, which could offer value if the cycle turns, but it also warns of deteriorating expectations. Dividend yield is a token 0.05%, so the patient shareholder is not being paid to wait. On a growth-adjusted basis, PEG of 1.67 leaves little margin of safety when profit growth is barely positive. I would put it on the watchlist, not in the shopping cart. The balance sheet needs scrutiny, though debt/equity is not available. I want to see at least a few quarters of profit margin recovery before I act. As Buffett would say, in the short run the market is a voting machine; but with profits flat, I need more evidence to call it a wonderful business.
Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer